Saturday, November 23, 2024
HomeTagsSociety

Society

Phio Pharmaceuticals Selected to Present at the Tumor Immune Microenvironment Workshop of the Society for Immunotherapy of Cancer

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics